Current and historical daily PE Ratio for Abbott Laboratories (
) from 1990 to Sep 25 2023. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Abbott Laboratories stock (ABT) PE ratio as of Sep 25 2023 is 33.5.
More Details
Abbott Laboratories (ABT) PE Ratio (TTM) Chart
Abbott Laboratories (ABT) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1255
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Abbott Laboratories PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2023-09-25 | 33.5 | 2023-07-21 | 39.0 |
| 2023-09-22 | 33.5 | 2023-07-20 | 38.2 |
| 2023-09-21 | 33.8 | 2023-07-19 | 36.6 |
| 2023-09-20 | 34.2 | 2023-07-18 | 36.5 |
| 2023-09-19 | 34.4 | 2023-07-17 | 36.5 |
| 2023-09-18 | 34.5 | 2023-07-14 | 36.8 |
| 2023-09-15 | 34.7 | 2023-07-13 | 36.8 |
| 2023-09-14 | 35.0 | 2023-07-12 | 36.5 |
| 2023-09-13 | 35.0 | 2023-07-11 | 36.7 |
| 2023-09-12 | 35.0 | 2023-07-10 | 36.5 |
| 2023-09-11 | 35.0 | 2023-07-07 | 36.3 |
| 2023-09-08 | 34.4 | 2023-07-06 | 36.6 |
| 2023-09-07 | 34.4 | 2023-07-05 | 36.6 |
| 2023-09-06 | 34.7 | 2023-07-03 | 36.6 |
| 2023-09-05 | 34.4 | 2023-06-30 | 37.2 |
| 2023-09-01 | 35.1 | 2023-06-29 | 36.7 |
| 2023-08-31 | 35.1 | 2023-06-28 | 36.7 |
| 2023-08-30 | 35.6 | 2023-06-27 | 32.8 |
| 2023-08-29 | 35.5 | 2023-06-26 | 33.0 |
| 2023-08-28 | 35.1 | 2023-06-23 | 32.8 |
| 2023-08-25 | 35.6 | 2023-06-22 | 32.9 |
| 2023-08-24 | 35.4 | 2023-06-21 | 32.3 |
| 2023-08-23 | 35.9 | 2023-06-20 | 32.4 |
| 2023-08-22 | 35.9 | 2023-06-16 | 32.3 |
| 2023-08-21 | 35.5 | 2023-06-15 | 31.9 |
| 2023-08-18 | 35.4 | 2023-06-14 | 31.4 |
| 2023-08-17 | 35.8 | 2023-06-13 | 31.0 |
| 2023-08-16 | 35.7 | 2023-06-12 | 30.8 |
| 2023-08-15 | 35.8 | 2023-06-09 | 30.9 |
| 2023-08-14 | 36.2 | 2023-06-08 | 30.6 |
| 2023-08-11 | 35.9 | 2023-06-07 | 30.9 |
| 2023-08-10 | 35.8 | 2023-06-06 | 31.2 |
| 2023-08-09 | 35.9 | 2023-06-05 | 31.5 |
| 2023-08-08 | 36.0 | 2023-06-02 | 31.7 |
| 2023-08-07 | 37.0 | 2023-06-01 | 31.3 |
| 2023-08-04 | 36.7 | 2023-05-31 | 31.0 |
| 2023-08-03 | 36.7 | 2023-05-30 | 30.9 |
| 2023-08-02 | 37.1 | 2023-05-26 | 31.3 |
| 2023-08-01 | 37.7 | 2023-05-25 | 31.1 |
| 2023-07-31 | 38.0 | 2023-05-24 | 31.6 |
| 2023-07-28 | 38.5 | 2023-05-23 | 32.1 |
| 2023-07-27 | 38.5 | 2023-05-22 | 32.9 |
| 2023-07-26 | 38.9 | 2023-05-19 | 33.1 |
| 2023-07-25 | 38.5 | 2023-05-18 | 33.0 |
| 2023-07-24 | 39.1 | 2023-05-17 | 33.1 |
Abbott Laboratories (ABT) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Abbott Laboratories
NAICS : 339112
SIC : 3841
ISIN : US0028241000
Compare
Compare
Traded in other countries / regions
ABT.USA0Q15.UKABT.MexicoABTT34.BrazilABL.GermanyABT.ArgentinaABT.ChileABT.AustriaABT.SwitzerlandABT_KZ.Kazakhstan IPO Date
1949-04-19Description
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers